Security key
40637HAF6
- Security type / class
- Debt / NOTE 1.000% 8/1
- Total 13F principal
- $658,912,150
- Total 13F market value
- $616,721,993
- SEC-reported market price (% of par)
- 93.09%
- Principal change
- -$4,060,700
- Number of holders
- 72
- Value change
- -$3,988,874
- Number of buys
- 31
- Number of sells
- 25
Report period
Q4 2023
Institutions
72
Top holders
10
40637HAF6 full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2024
Previous quarter: Q3 2023
Broader feeds
Reporting periods
Holder history for CUSIP 40637HAF6
Recent filing periods:
Ownership snapshot
Top reported holders of 40637HAF6 - HALOZYME THERAPEUTICS INC - NOTE 1.000% 8/1 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
—
Disclosed value leader
—
Comparable rows
0/0
Latest evidence
—
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
13F holder rows
Institutional holders as of Q4 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
72
Principal
$658,912,150
Rows available
72
| Investor | Option | Weight % | Change % | SEC-reported value | * Price (% of par) | Principal | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
64
Q4 2023 holders
72
Holder diff
8
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 value | Q4 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend